SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-271244
Filing Date
2012-06-15
Accepted
2012-06-14 20:04:16
Documents
2
Period of Report
2012-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d367717d8k.htm 8-K 16351
2 JOINDER AGREEMENT d367717dex101.htm EX-10.1 106254
  Complete submission text file 0001193125-12-271244.txt   123940
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 12908659
SIC: 2834 Pharmaceutical Preparations